James Tobin

James Tobin

Fortune : 12 M $ au 30/06/2026

81 ans
Health Technology
Commercial Services
Electronic Technology

Profil

James R.
Tobin
is currently Chairman at TransMedics, Inc. and TransMedics Group, Inc. since 2011.
He serves as Independent Director at Globus Medical, Inc. since 2015, Director at Impulse Dynamics NV since 2021, Lead Independent Director at Lyra Therapeutics, Inc. since 2022, and Director at Xenter, Inc. Formerly, Mr. Tobin was President, Chief Executive Officer & Director at Boston Scientific Corp.
from 1999 to 2009; President & Chief Executive Officer at Biogen, Inc. from 1997 to 1999; Director at Creative Biomolecules, Inc. from 1995 to 2000; Director at Applera Corp.
from 1999 to 2008; Independent Director at Curis, Inc. from 2011 to 2015; Director at Medical Simulation Corp.
from 2012 to 2018; Director at CardioDx, Inc. from 2014 to 2017; Director at Aptus Endosystems, Inc. from 2011 to 2015; Independent Director at Chiasma, Inc. from 2015 to 2016; Independent Non-Executive Director at Oxford Immunotec Global Ltd. from 2014 to 2021; Director at Oxford Immunotec Ltd. from 2014 to 2021; Director at Biomedical Sciences Careers Program, Inc.; Director at Applied Biosystems, Inc. from 1999 to 2008; Director at Quest Diagnostics TB LLC from 2014 to 2021; Director at Corindus Vascular Robotics, Inc. from 2018 to 2019; Director at Resolys Bio, Inc.; President & Chief Operating Officer at Baxter International, Inc. from 1972 to 1994; and Principal at US Department of the Navy (District of Columbia) in 1972.
Education includes an MBA from Harvard Business School conferred in 1968 and an undergraduate degree from Harvard College conferred in 1996.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
20/05/2026 180 127 ( 0,53% ) 12 M $ 30/06/2026
18/03/2025 0 ( -.--% ) - $ 30/06/2026
31/03/2026 0 ( -.--% ) - $ 30/06/2026

Postes actifs de James Tobin

SociétésPosteDébut
GLOBUS MEDICAL, INC. Directeur/Membre du Conseil 28/08/2015
TRANSMEDICS GROUP, INC. Président 01/01/2011
LYRA THERAPEUTICS, INC. Directeur/Membre du Conseil 07/03/2022
Directeur/Membre du Conseil 11/11/2021
Directeur/Membre du Conseil -
Président 01/07/2011

Anciens postes connus de James Tobin

SociétésPosteFin
OXFORD IMMUNOTEC GLOBAL PLC Directeur/Membre du Conseil 08/03/2021
Directeur/Membre du Conseil 01/03/2021
Directeur/Membre du Conseil 01/01/2021
░░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de James Tobin

Formation de James Tobin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

79

Relations au 1er degré

26

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées26

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Government

Biomedical Sciences Careers Program, Inc.

Electronic Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Electronic Technology

  1. Bourse
  2. Insiders
  3. James Tobin